Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmaceutical Technology
44m
“PBMs favour high list prices”- Novo Nordisk CEO targets PBMs in US Senate hearing
Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Left note, bail denied
Diagnosed with Parkinson's
Russian aircraft detected
Contempt charge coming?
Devils Tower climber dies
1/3 think they have CTE
Asks to be put on NY ballot
Texas sues Biden admin
Colo. shooter found guilty
Ammonia-powered tug sails
Returning Indian antiquities
John becomes Category 3
To shut down TikTok Music
Didn't authorize apology
Seeks NIL compensation
Friedkin set to buy Everton
DOJ to sue Visa?
Reds fire manager
OR removes 1,200+ voters
Gold prices hit all-time high
NY reports death from EEE
Calif. school phone ban law
UAE president WH meeting
Conn. counterfeit drug bust
Closing last full-size store
California sues ExxonMobil
Consumer confidence falls
NE electoral change blocked
FBI: Violent crime declined
Addresses United Nations
Feedback